Medical Care
Global Molecular Pharming Market Research Report 2025
- May 05, 25
- ID: 226112
- Pages: 93
- Figures: 99
- Views: 33
The global market for Molecular Pharming was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Molecular pharming, also known as biopharming, is a technology that involves the use of genetically modified plants to produce pharmaceuticals or industrial chemicals. This approach relies on the ability of plants to serve as bioreactors for the production of proteins and other complex molecules.
To produce a desired protein, the gene encoding the protein is first inserted into the plant genome. The plant is then grown under controlled conditions, and the protein is harvested from the plant tissue. The protein can then be purified and used for a variety of applications, including drug development, vaccines, and enzyme replacement therapies.
Molecular pharming has several advantages over traditional methods of protein production. Plants are relatively easy to grow and require minimal processing, which can result in lower production costs. Additionally, plant-based production systems are considered to be safer than those that use animal cells or bacteria, as plants are less likely to transmit viruses or other contaminants.
Despite its potential benefits, molecular pharming also has some limitations and challenges. One of the main challenges is ensuring that the plant-produced proteins are properly folded and functional, which can be influenced by factors such as post-translational modifications, environmental conditions, and the choice of plant species. Additionally, there are regulatory and ethical considerations associated with using genetically modified plants for pharmaceutical production.
North American market for Molecular Pharming is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Molecular Pharming is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Molecular Pharming in Recombinant Antibodies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Molecular Pharming include Medicago Inc, Meristem Therapeutics S.A. (Ventria Bioscience), Miruku, Moolec Science Limited, mozza, Nobell Foods, Agrenvec S.L, Bright Biotech, Core Biogenesis, Diamante SRL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Molecular Pharming, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Pharming.
The Molecular Pharming market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Pharming market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Pharming companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medicago Inc
Meristem Therapeutics S.A. (Ventria Bioscience)
Miruku
Moolec Science Limited
mozza
Nobell Foods
Agrenvec S.L
Bright Biotech
Core Biogenesis
Diamante SRL
Leaf Systems International Limited
ORF Genetics
Pfizer, Inc.
ProdiGene Inc
Protalix Biotherapeutics, Inc
Tiamat Sciences
Segment by Type
Gene Gun
Agroinfiltration
Electroporation
Agrobacterium-Mediated Gene Transfer
Segment by Application
Recombinant Antibodies
Hormones, Vaccines
Industrial Enzymes
Proteins & Protein-Based Materials
Technical Reagents
Nutritional Products
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Pharming company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Molecular pharming, also known as biopharming, is a technology that involves the use of genetically modified plants to produce pharmaceuticals or industrial chemicals. This approach relies on the ability of plants to serve as bioreactors for the production of proteins and other complex molecules.
To produce a desired protein, the gene encoding the protein is first inserted into the plant genome. The plant is then grown under controlled conditions, and the protein is harvested from the plant tissue. The protein can then be purified and used for a variety of applications, including drug development, vaccines, and enzyme replacement therapies.
Molecular pharming has several advantages over traditional methods of protein production. Plants are relatively easy to grow and require minimal processing, which can result in lower production costs. Additionally, plant-based production systems are considered to be safer than those that use animal cells or bacteria, as plants are less likely to transmit viruses or other contaminants.
Despite its potential benefits, molecular pharming also has some limitations and challenges. One of the main challenges is ensuring that the plant-produced proteins are properly folded and functional, which can be influenced by factors such as post-translational modifications, environmental conditions, and the choice of plant species. Additionally, there are regulatory and ethical considerations associated with using genetically modified plants for pharmaceutical production.
North American market for Molecular Pharming is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Molecular Pharming is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Molecular Pharming in Recombinant Antibodies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Molecular Pharming include Medicago Inc, Meristem Therapeutics S.A. (Ventria Bioscience), Miruku, Moolec Science Limited, mozza, Nobell Foods, Agrenvec S.L, Bright Biotech, Core Biogenesis, Diamante SRL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Molecular Pharming, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Pharming.
The Molecular Pharming market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Pharming market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Pharming companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medicago Inc
Meristem Therapeutics S.A. (Ventria Bioscience)
Miruku
Moolec Science Limited
mozza
Nobell Foods
Agrenvec S.L
Bright Biotech
Core Biogenesis
Diamante SRL
Leaf Systems International Limited
ORF Genetics
Pfizer, Inc.
ProdiGene Inc
Protalix Biotherapeutics, Inc
Tiamat Sciences
Segment by Type
Gene Gun
Agroinfiltration
Electroporation
Agrobacterium-Mediated Gene Transfer
Segment by Application
Recombinant Antibodies
Hormones, Vaccines
Industrial Enzymes
Proteins & Protein-Based Materials
Technical Reagents
Nutritional Products
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Pharming company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Pharming Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gene Gun
1.2.3 Agroinfiltration
1.2.4 Electroporation
1.2.5 Agrobacterium-Mediated Gene Transfer
1.3 Market by Application
1.3.1 Global Molecular Pharming Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Recombinant Antibodies
1.3.3 Hormones, Vaccines
1.3.4 Industrial Enzymes
1.3.5 Proteins & Protein-Based Materials
1.3.6 Technical Reagents
1.3.7 Nutritional Products
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Pharming Market Perspective (2020-2031)
2.2 Global Molecular Pharming Growth Trends by Region
2.2.1 Global Molecular Pharming Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Molecular Pharming Historic Market Size by Region (2020-2025)
2.2.3 Molecular Pharming Forecasted Market Size by Region (2026-2031)
2.3 Molecular Pharming Market Dynamics
2.3.1 Molecular Pharming Industry Trends
2.3.2 Molecular Pharming Market Drivers
2.3.3 Molecular Pharming Market Challenges
2.3.4 Molecular Pharming Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Pharming Players by Revenue
3.1.1 Global Top Molecular Pharming Players by Revenue (2020-2025)
3.1.2 Global Molecular Pharming Revenue Market Share by Players (2020-2025)
3.2 Global Molecular Pharming Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Molecular Pharming Revenue
3.4 Global Molecular Pharming Market Concentration Ratio
3.4.1 Global Molecular Pharming Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Pharming Revenue in 2024
3.5 Global Key Players of Molecular Pharming Head office and Area Served
3.6 Global Key Players of Molecular Pharming, Product and Application
3.7 Global Key Players of Molecular Pharming, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Pharming Breakdown Data by Type
4.1 Global Molecular Pharming Historic Market Size by Type (2020-2025)
4.2 Global Molecular Pharming Forecasted Market Size by Type (2026-2031)
5 Molecular Pharming Breakdown Data by Application
5.1 Global Molecular Pharming Historic Market Size by Application (2020-2025)
5.2 Global Molecular Pharming Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Molecular Pharming Market Size (2020-2031)
6.2 North America Molecular Pharming Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Molecular Pharming Market Size by Country (2020-2025)
6.4 North America Molecular Pharming Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Pharming Market Size (2020-2031)
7.2 Europe Molecular Pharming Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Molecular Pharming Market Size by Country (2020-2025)
7.4 Europe Molecular Pharming Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Pharming Market Size (2020-2031)
8.2 Asia-Pacific Molecular Pharming Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Molecular Pharming Market Size by Region (2020-2025)
8.4 Asia-Pacific Molecular Pharming Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Pharming Market Size (2020-2031)
9.2 Latin America Molecular Pharming Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Molecular Pharming Market Size by Country (2020-2025)
9.4 Latin America Molecular Pharming Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Pharming Market Size (2020-2031)
10.2 Middle East & Africa Molecular Pharming Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Molecular Pharming Market Size by Country (2020-2025)
10.4 Middle East & Africa Molecular Pharming Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medicago Inc
11.1.1 Medicago Inc Company Details
11.1.2 Medicago Inc Business Overview
11.1.3 Medicago Inc Molecular Pharming Introduction
11.1.4 Medicago Inc Revenue in Molecular Pharming Business (2020-2025)
11.1.5 Medicago Inc Recent Development
11.2 Meristem Therapeutics S.A. (Ventria Bioscience)
11.2.1 Meristem Therapeutics S.A. (Ventria Bioscience) Company Details
11.2.2 Meristem Therapeutics S.A. (Ventria Bioscience) Business Overview
11.2.3 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Introduction
11.2.4 Meristem Therapeutics S.A. (Ventria Bioscience) Revenue in Molecular Pharming Business (2020-2025)
11.2.5 Meristem Therapeutics S.A. (Ventria Bioscience) Recent Development
11.3 Miruku
11.3.1 Miruku Company Details
11.3.2 Miruku Business Overview
11.3.3 Miruku Molecular Pharming Introduction
11.3.4 Miruku Revenue in Molecular Pharming Business (2020-2025)
11.3.5 Miruku Recent Development
11.4 Moolec Science Limited
11.4.1 Moolec Science Limited Company Details
11.4.2 Moolec Science Limited Business Overview
11.4.3 Moolec Science Limited Molecular Pharming Introduction
11.4.4 Moolec Science Limited Revenue in Molecular Pharming Business (2020-2025)
11.4.5 Moolec Science Limited Recent Development
11.5 mozza
11.5.1 mozza Company Details
11.5.2 mozza Business Overview
11.5.3 mozza Molecular Pharming Introduction
11.5.4 mozza Revenue in Molecular Pharming Business (2020-2025)
11.5.5 mozza Recent Development
11.6 Nobell Foods
11.6.1 Nobell Foods Company Details
11.6.2 Nobell Foods Business Overview
11.6.3 Nobell Foods Molecular Pharming Introduction
11.6.4 Nobell Foods Revenue in Molecular Pharming Business (2020-2025)
11.6.5 Nobell Foods Recent Development
11.7 Agrenvec S.L
11.7.1 Agrenvec S.L Company Details
11.7.2 Agrenvec S.L Business Overview
11.7.3 Agrenvec S.L Molecular Pharming Introduction
11.7.4 Agrenvec S.L Revenue in Molecular Pharming Business (2020-2025)
11.7.5 Agrenvec S.L Recent Development
11.8 Bright Biotech
11.8.1 Bright Biotech Company Details
11.8.2 Bright Biotech Business Overview
11.8.3 Bright Biotech Molecular Pharming Introduction
11.8.4 Bright Biotech Revenue in Molecular Pharming Business (2020-2025)
11.8.5 Bright Biotech Recent Development
11.9 Core Biogenesis
11.9.1 Core Biogenesis Company Details
11.9.2 Core Biogenesis Business Overview
11.9.3 Core Biogenesis Molecular Pharming Introduction
11.9.4 Core Biogenesis Revenue in Molecular Pharming Business (2020-2025)
11.9.5 Core Biogenesis Recent Development
11.10 Diamante SRL
11.10.1 Diamante SRL Company Details
11.10.2 Diamante SRL Business Overview
11.10.3 Diamante SRL Molecular Pharming Introduction
11.10.4 Diamante SRL Revenue in Molecular Pharming Business (2020-2025)
11.10.5 Diamante SRL Recent Development
11.11 Leaf Systems International Limited
11.11.1 Leaf Systems International Limited Company Details
11.11.2 Leaf Systems International Limited Business Overview
11.11.3 Leaf Systems International Limited Molecular Pharming Introduction
11.11.4 Leaf Systems International Limited Revenue in Molecular Pharming Business (2020-2025)
11.11.5 Leaf Systems International Limited Recent Development
11.12 ORF Genetics
11.12.1 ORF Genetics Company Details
11.12.2 ORF Genetics Business Overview
11.12.3 ORF Genetics Molecular Pharming Introduction
11.12.4 ORF Genetics Revenue in Molecular Pharming Business (2020-2025)
11.12.5 ORF Genetics Recent Development
11.13 Pfizer, Inc.
11.13.1 Pfizer, Inc. Company Details
11.13.2 Pfizer, Inc. Business Overview
11.13.3 Pfizer, Inc. Molecular Pharming Introduction
11.13.4 Pfizer, Inc. Revenue in Molecular Pharming Business (2020-2025)
11.13.5 Pfizer, Inc. Recent Development
11.14 ProdiGene Inc
11.14.1 ProdiGene Inc Company Details
11.14.2 ProdiGene Inc Business Overview
11.14.3 ProdiGene Inc Molecular Pharming Introduction
11.14.4 ProdiGene Inc Revenue in Molecular Pharming Business (2020-2025)
11.14.5 ProdiGene Inc Recent Development
11.15 Protalix Biotherapeutics, Inc
11.15.1 Protalix Biotherapeutics, Inc Company Details
11.15.2 Protalix Biotherapeutics, Inc Business Overview
11.15.3 Protalix Biotherapeutics, Inc Molecular Pharming Introduction
11.15.4 Protalix Biotherapeutics, Inc Revenue in Molecular Pharming Business (2020-2025)
11.15.5 Protalix Biotherapeutics, Inc Recent Development
11.16 Tiamat Sciences
11.16.1 Tiamat Sciences Company Details
11.16.2 Tiamat Sciences Business Overview
11.16.3 Tiamat Sciences Molecular Pharming Introduction
11.16.4 Tiamat Sciences Revenue in Molecular Pharming Business (2020-2025)
11.16.5 Tiamat Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Pharming Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Gene Gun
1.2.3 Agroinfiltration
1.2.4 Electroporation
1.2.5 Agrobacterium-Mediated Gene Transfer
1.3 Market by Application
1.3.1 Global Molecular Pharming Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Recombinant Antibodies
1.3.3 Hormones, Vaccines
1.3.4 Industrial Enzymes
1.3.5 Proteins & Protein-Based Materials
1.3.6 Technical Reagents
1.3.7 Nutritional Products
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Pharming Market Perspective (2020-2031)
2.2 Global Molecular Pharming Growth Trends by Region
2.2.1 Global Molecular Pharming Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Molecular Pharming Historic Market Size by Region (2020-2025)
2.2.3 Molecular Pharming Forecasted Market Size by Region (2026-2031)
2.3 Molecular Pharming Market Dynamics
2.3.1 Molecular Pharming Industry Trends
2.3.2 Molecular Pharming Market Drivers
2.3.3 Molecular Pharming Market Challenges
2.3.4 Molecular Pharming Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Pharming Players by Revenue
3.1.1 Global Top Molecular Pharming Players by Revenue (2020-2025)
3.1.2 Global Molecular Pharming Revenue Market Share by Players (2020-2025)
3.2 Global Molecular Pharming Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Molecular Pharming Revenue
3.4 Global Molecular Pharming Market Concentration Ratio
3.4.1 Global Molecular Pharming Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Pharming Revenue in 2024
3.5 Global Key Players of Molecular Pharming Head office and Area Served
3.6 Global Key Players of Molecular Pharming, Product and Application
3.7 Global Key Players of Molecular Pharming, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Pharming Breakdown Data by Type
4.1 Global Molecular Pharming Historic Market Size by Type (2020-2025)
4.2 Global Molecular Pharming Forecasted Market Size by Type (2026-2031)
5 Molecular Pharming Breakdown Data by Application
5.1 Global Molecular Pharming Historic Market Size by Application (2020-2025)
5.2 Global Molecular Pharming Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Molecular Pharming Market Size (2020-2031)
6.2 North America Molecular Pharming Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Molecular Pharming Market Size by Country (2020-2025)
6.4 North America Molecular Pharming Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Pharming Market Size (2020-2031)
7.2 Europe Molecular Pharming Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Molecular Pharming Market Size by Country (2020-2025)
7.4 Europe Molecular Pharming Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Pharming Market Size (2020-2031)
8.2 Asia-Pacific Molecular Pharming Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Molecular Pharming Market Size by Region (2020-2025)
8.4 Asia-Pacific Molecular Pharming Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Pharming Market Size (2020-2031)
9.2 Latin America Molecular Pharming Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Molecular Pharming Market Size by Country (2020-2025)
9.4 Latin America Molecular Pharming Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Pharming Market Size (2020-2031)
10.2 Middle East & Africa Molecular Pharming Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Molecular Pharming Market Size by Country (2020-2025)
10.4 Middle East & Africa Molecular Pharming Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medicago Inc
11.1.1 Medicago Inc Company Details
11.1.2 Medicago Inc Business Overview
11.1.3 Medicago Inc Molecular Pharming Introduction
11.1.4 Medicago Inc Revenue in Molecular Pharming Business (2020-2025)
11.1.5 Medicago Inc Recent Development
11.2 Meristem Therapeutics S.A. (Ventria Bioscience)
11.2.1 Meristem Therapeutics S.A. (Ventria Bioscience) Company Details
11.2.2 Meristem Therapeutics S.A. (Ventria Bioscience) Business Overview
11.2.3 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Introduction
11.2.4 Meristem Therapeutics S.A. (Ventria Bioscience) Revenue in Molecular Pharming Business (2020-2025)
11.2.5 Meristem Therapeutics S.A. (Ventria Bioscience) Recent Development
11.3 Miruku
11.3.1 Miruku Company Details
11.3.2 Miruku Business Overview
11.3.3 Miruku Molecular Pharming Introduction
11.3.4 Miruku Revenue in Molecular Pharming Business (2020-2025)
11.3.5 Miruku Recent Development
11.4 Moolec Science Limited
11.4.1 Moolec Science Limited Company Details
11.4.2 Moolec Science Limited Business Overview
11.4.3 Moolec Science Limited Molecular Pharming Introduction
11.4.4 Moolec Science Limited Revenue in Molecular Pharming Business (2020-2025)
11.4.5 Moolec Science Limited Recent Development
11.5 mozza
11.5.1 mozza Company Details
11.5.2 mozza Business Overview
11.5.3 mozza Molecular Pharming Introduction
11.5.4 mozza Revenue in Molecular Pharming Business (2020-2025)
11.5.5 mozza Recent Development
11.6 Nobell Foods
11.6.1 Nobell Foods Company Details
11.6.2 Nobell Foods Business Overview
11.6.3 Nobell Foods Molecular Pharming Introduction
11.6.4 Nobell Foods Revenue in Molecular Pharming Business (2020-2025)
11.6.5 Nobell Foods Recent Development
11.7 Agrenvec S.L
11.7.1 Agrenvec S.L Company Details
11.7.2 Agrenvec S.L Business Overview
11.7.3 Agrenvec S.L Molecular Pharming Introduction
11.7.4 Agrenvec S.L Revenue in Molecular Pharming Business (2020-2025)
11.7.5 Agrenvec S.L Recent Development
11.8 Bright Biotech
11.8.1 Bright Biotech Company Details
11.8.2 Bright Biotech Business Overview
11.8.3 Bright Biotech Molecular Pharming Introduction
11.8.4 Bright Biotech Revenue in Molecular Pharming Business (2020-2025)
11.8.5 Bright Biotech Recent Development
11.9 Core Biogenesis
11.9.1 Core Biogenesis Company Details
11.9.2 Core Biogenesis Business Overview
11.9.3 Core Biogenesis Molecular Pharming Introduction
11.9.4 Core Biogenesis Revenue in Molecular Pharming Business (2020-2025)
11.9.5 Core Biogenesis Recent Development
11.10 Diamante SRL
11.10.1 Diamante SRL Company Details
11.10.2 Diamante SRL Business Overview
11.10.3 Diamante SRL Molecular Pharming Introduction
11.10.4 Diamante SRL Revenue in Molecular Pharming Business (2020-2025)
11.10.5 Diamante SRL Recent Development
11.11 Leaf Systems International Limited
11.11.1 Leaf Systems International Limited Company Details
11.11.2 Leaf Systems International Limited Business Overview
11.11.3 Leaf Systems International Limited Molecular Pharming Introduction
11.11.4 Leaf Systems International Limited Revenue in Molecular Pharming Business (2020-2025)
11.11.5 Leaf Systems International Limited Recent Development
11.12 ORF Genetics
11.12.1 ORF Genetics Company Details
11.12.2 ORF Genetics Business Overview
11.12.3 ORF Genetics Molecular Pharming Introduction
11.12.4 ORF Genetics Revenue in Molecular Pharming Business (2020-2025)
11.12.5 ORF Genetics Recent Development
11.13 Pfizer, Inc.
11.13.1 Pfizer, Inc. Company Details
11.13.2 Pfizer, Inc. Business Overview
11.13.3 Pfizer, Inc. Molecular Pharming Introduction
11.13.4 Pfizer, Inc. Revenue in Molecular Pharming Business (2020-2025)
11.13.5 Pfizer, Inc. Recent Development
11.14 ProdiGene Inc
11.14.1 ProdiGene Inc Company Details
11.14.2 ProdiGene Inc Business Overview
11.14.3 ProdiGene Inc Molecular Pharming Introduction
11.14.4 ProdiGene Inc Revenue in Molecular Pharming Business (2020-2025)
11.14.5 ProdiGene Inc Recent Development
11.15 Protalix Biotherapeutics, Inc
11.15.1 Protalix Biotherapeutics, Inc Company Details
11.15.2 Protalix Biotherapeutics, Inc Business Overview
11.15.3 Protalix Biotherapeutics, Inc Molecular Pharming Introduction
11.15.4 Protalix Biotherapeutics, Inc Revenue in Molecular Pharming Business (2020-2025)
11.15.5 Protalix Biotherapeutics, Inc Recent Development
11.16 Tiamat Sciences
11.16.1 Tiamat Sciences Company Details
11.16.2 Tiamat Sciences Business Overview
11.16.3 Tiamat Sciences Molecular Pharming Introduction
11.16.4 Tiamat Sciences Revenue in Molecular Pharming Business (2020-2025)
11.16.5 Tiamat Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Molecular Pharming Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Gene Gun
Table 3. Key Players of Agroinfiltration
Table 4. Key Players of Electroporation
Table 5. Key Players of Agrobacterium-Mediated Gene Transfer
Table 6. Global Molecular Pharming Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Molecular Pharming Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Molecular Pharming Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Molecular Pharming Market Share by Region (2020-2025)
Table 10. Global Molecular Pharming Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Molecular Pharming Market Share by Region (2026-2031)
Table 12. Molecular Pharming Market Trends
Table 13. Molecular Pharming Market Drivers
Table 14. Molecular Pharming Market Challenges
Table 15. Molecular Pharming Market Restraints
Table 16. Global Molecular Pharming Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Molecular Pharming Market Share by Players (2020-2025)
Table 18. Global Top Molecular Pharming Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Pharming as of 2024)
Table 19. Ranking of Global Top Molecular Pharming Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Molecular Pharming Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Molecular Pharming, Headquarters and Area Served
Table 22. Global Key Players of Molecular Pharming, Product and Application
Table 23. Global Key Players of Molecular Pharming, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Pharming Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Molecular Pharming Revenue Market Share by Type (2020-2025)
Table 27. Global Molecular Pharming Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Molecular Pharming Revenue Market Share by Type (2026-2031)
Table 29. Global Molecular Pharming Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Molecular Pharming Revenue Market Share by Application (2020-2025)
Table 31. Global Molecular Pharming Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Molecular Pharming Revenue Market Share by Application (2026-2031)
Table 33. North America Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Molecular Pharming Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Molecular Pharming Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Molecular Pharming Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Molecular Pharming Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Molecular Pharming Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Molecular Pharming Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Molecular Pharming Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Molecular Pharming Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Molecular Pharming Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Molecular Pharming Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Molecular Pharming Market Size by Country (2026-2031) & (US$ Million)
Table 48. Medicago Inc Company Details
Table 49. Medicago Inc Business Overview
Table 50. Medicago Inc Molecular Pharming Product
Table 51. Medicago Inc Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 52. Medicago Inc Recent Development
Table 53. Meristem Therapeutics S.A. (Ventria Bioscience) Company Details
Table 54. Meristem Therapeutics S.A. (Ventria Bioscience) Business Overview
Table 55. Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product
Table 56. Meristem Therapeutics S.A. (Ventria Bioscience) Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 57. Meristem Therapeutics S.A. (Ventria Bioscience) Recent Development
Table 58. Miruku Company Details
Table 59. Miruku Business Overview
Table 60. Miruku Molecular Pharming Product
Table 61. Miruku Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 62. Miruku Recent Development
Table 63. Moolec Science Limited Company Details
Table 64. Moolec Science Limited Business Overview
Table 65. Moolec Science Limited Molecular Pharming Product
Table 66. Moolec Science Limited Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 67. Moolec Science Limited Recent Development
Table 68. mozza Company Details
Table 69. mozza Business Overview
Table 70. mozza Molecular Pharming Product
Table 71. mozza Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 72. mozza Recent Development
Table 73. Nobell Foods Company Details
Table 74. Nobell Foods Business Overview
Table 75. Nobell Foods Molecular Pharming Product
Table 76. Nobell Foods Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 77. Nobell Foods Recent Development
Table 78. Agrenvec S.L Company Details
Table 79. Agrenvec S.L Business Overview
Table 80. Agrenvec S.L Molecular Pharming Product
Table 81. Agrenvec S.L Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 82. Agrenvec S.L Recent Development
Table 83. Bright Biotech Company Details
Table 84. Bright Biotech Business Overview
Table 85. Bright Biotech Molecular Pharming Product
Table 86. Bright Biotech Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 87. Bright Biotech Recent Development
Table 88. Core Biogenesis Company Details
Table 89. Core Biogenesis Business Overview
Table 90. Core Biogenesis Molecular Pharming Product
Table 91. Core Biogenesis Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 92. Core Biogenesis Recent Development
Table 93. Diamante SRL Company Details
Table 94. Diamante SRL Business Overview
Table 95. Diamante SRL Molecular Pharming Product
Table 96. Diamante SRL Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 97. Diamante SRL Recent Development
Table 98. Leaf Systems International Limited Company Details
Table 99. Leaf Systems International Limited Business Overview
Table 100. Leaf Systems International Limited Molecular Pharming Product
Table 101. Leaf Systems International Limited Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 102. Leaf Systems International Limited Recent Development
Table 103. ORF Genetics Company Details
Table 104. ORF Genetics Business Overview
Table 105. ORF Genetics Molecular Pharming Product
Table 106. ORF Genetics Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 107. ORF Genetics Recent Development
Table 108. Pfizer, Inc. Company Details
Table 109. Pfizer, Inc. Business Overview
Table 110. Pfizer, Inc. Molecular Pharming Product
Table 111. Pfizer, Inc. Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 112. Pfizer, Inc. Recent Development
Table 113. ProdiGene Inc Company Details
Table 114. ProdiGene Inc Business Overview
Table 115. ProdiGene Inc Molecular Pharming Product
Table 116. ProdiGene Inc Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 117. ProdiGene Inc Recent Development
Table 118. Protalix Biotherapeutics, Inc Company Details
Table 119. Protalix Biotherapeutics, Inc Business Overview
Table 120. Protalix Biotherapeutics, Inc Molecular Pharming Product
Table 121. Protalix Biotherapeutics, Inc Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 122. Protalix Biotherapeutics, Inc Recent Development
Table 123. Tiamat Sciences Company Details
Table 124. Tiamat Sciences Business Overview
Table 125. Tiamat Sciences Molecular Pharming Product
Table 126. Tiamat Sciences Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 127. Tiamat Sciences Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Molecular Pharming Picture
Figure 2. Global Molecular Pharming Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Molecular Pharming Market Share by Type: 2024 VS 2031
Figure 4. Gene Gun Features
Figure 5. Agroinfiltration Features
Figure 6. Electroporation Features
Figure 7. Agrobacterium-Mediated Gene Transfer Features
Figure 8. Global Molecular Pharming Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Molecular Pharming Market Share by Application: 2024 VS 2031
Figure 10. Recombinant Antibodies Case Studies
Figure 11. Hormones, Vaccines Case Studies
Figure 12. Industrial Enzymes Case Studies
Figure 13. Proteins & Protein-Based Materials Case Studies
Figure 14. Technical Reagents Case Studies
Figure 15. Nutritional Products Case Studies
Figure 16. Molecular Pharming Report Years Considered
Figure 17. Global Molecular Pharming Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Molecular Pharming Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Molecular Pharming Market Share by Region: 2024 VS 2031
Figure 20. Global Molecular Pharming Market Share by Players in 2024
Figure 21. Global Top Molecular Pharming Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Pharming as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Molecular Pharming Revenue in 2024
Figure 23. North America Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Molecular Pharming Market Share by Country (2020-2031)
Figure 25. United States Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Molecular Pharming Market Share by Country (2020-2031)
Figure 29. Germany Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Molecular Pharming Market Share by Region (2020-2031)
Figure 37. China Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Molecular Pharming Market Share by Country (2020-2031)
Figure 45. Mexico Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Molecular Pharming Market Share by Country (2020-2031)
Figure 49. Turkey Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Medicago Inc Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 53. Meristem Therapeutics S.A. (Ventria Bioscience) Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 54. Miruku Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 55. Moolec Science Limited Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 56. mozza Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 57. Nobell Foods Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 58. Agrenvec S.L Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 59. Bright Biotech Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 60. Core Biogenesis Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 61. Diamante SRL Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 62. Leaf Systems International Limited Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 63. ORF Genetics Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 64. Pfizer, Inc. Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 65. ProdiGene Inc Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 66. Protalix Biotherapeutics, Inc Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 67. Tiamat Sciences Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Molecular Pharming Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Gene Gun
Table 3. Key Players of Agroinfiltration
Table 4. Key Players of Electroporation
Table 5. Key Players of Agrobacterium-Mediated Gene Transfer
Table 6. Global Molecular Pharming Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Molecular Pharming Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Molecular Pharming Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Molecular Pharming Market Share by Region (2020-2025)
Table 10. Global Molecular Pharming Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Molecular Pharming Market Share by Region (2026-2031)
Table 12. Molecular Pharming Market Trends
Table 13. Molecular Pharming Market Drivers
Table 14. Molecular Pharming Market Challenges
Table 15. Molecular Pharming Market Restraints
Table 16. Global Molecular Pharming Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Molecular Pharming Market Share by Players (2020-2025)
Table 18. Global Top Molecular Pharming Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Pharming as of 2024)
Table 19. Ranking of Global Top Molecular Pharming Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Molecular Pharming Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Molecular Pharming, Headquarters and Area Served
Table 22. Global Key Players of Molecular Pharming, Product and Application
Table 23. Global Key Players of Molecular Pharming, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Pharming Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Molecular Pharming Revenue Market Share by Type (2020-2025)
Table 27. Global Molecular Pharming Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Molecular Pharming Revenue Market Share by Type (2026-2031)
Table 29. Global Molecular Pharming Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Molecular Pharming Revenue Market Share by Application (2020-2025)
Table 31. Global Molecular Pharming Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Molecular Pharming Revenue Market Share by Application (2026-2031)
Table 33. North America Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Molecular Pharming Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Molecular Pharming Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Molecular Pharming Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Molecular Pharming Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Molecular Pharming Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Molecular Pharming Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Molecular Pharming Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Molecular Pharming Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Molecular Pharming Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Molecular Pharming Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Molecular Pharming Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Molecular Pharming Market Size by Country (2026-2031) & (US$ Million)
Table 48. Medicago Inc Company Details
Table 49. Medicago Inc Business Overview
Table 50. Medicago Inc Molecular Pharming Product
Table 51. Medicago Inc Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 52. Medicago Inc Recent Development
Table 53. Meristem Therapeutics S.A. (Ventria Bioscience) Company Details
Table 54. Meristem Therapeutics S.A. (Ventria Bioscience) Business Overview
Table 55. Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product
Table 56. Meristem Therapeutics S.A. (Ventria Bioscience) Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 57. Meristem Therapeutics S.A. (Ventria Bioscience) Recent Development
Table 58. Miruku Company Details
Table 59. Miruku Business Overview
Table 60. Miruku Molecular Pharming Product
Table 61. Miruku Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 62. Miruku Recent Development
Table 63. Moolec Science Limited Company Details
Table 64. Moolec Science Limited Business Overview
Table 65. Moolec Science Limited Molecular Pharming Product
Table 66. Moolec Science Limited Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 67. Moolec Science Limited Recent Development
Table 68. mozza Company Details
Table 69. mozza Business Overview
Table 70. mozza Molecular Pharming Product
Table 71. mozza Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 72. mozza Recent Development
Table 73. Nobell Foods Company Details
Table 74. Nobell Foods Business Overview
Table 75. Nobell Foods Molecular Pharming Product
Table 76. Nobell Foods Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 77. Nobell Foods Recent Development
Table 78. Agrenvec S.L Company Details
Table 79. Agrenvec S.L Business Overview
Table 80. Agrenvec S.L Molecular Pharming Product
Table 81. Agrenvec S.L Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 82. Agrenvec S.L Recent Development
Table 83. Bright Biotech Company Details
Table 84. Bright Biotech Business Overview
Table 85. Bright Biotech Molecular Pharming Product
Table 86. Bright Biotech Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 87. Bright Biotech Recent Development
Table 88. Core Biogenesis Company Details
Table 89. Core Biogenesis Business Overview
Table 90. Core Biogenesis Molecular Pharming Product
Table 91. Core Biogenesis Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 92. Core Biogenesis Recent Development
Table 93. Diamante SRL Company Details
Table 94. Diamante SRL Business Overview
Table 95. Diamante SRL Molecular Pharming Product
Table 96. Diamante SRL Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 97. Diamante SRL Recent Development
Table 98. Leaf Systems International Limited Company Details
Table 99. Leaf Systems International Limited Business Overview
Table 100. Leaf Systems International Limited Molecular Pharming Product
Table 101. Leaf Systems International Limited Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 102. Leaf Systems International Limited Recent Development
Table 103. ORF Genetics Company Details
Table 104. ORF Genetics Business Overview
Table 105. ORF Genetics Molecular Pharming Product
Table 106. ORF Genetics Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 107. ORF Genetics Recent Development
Table 108. Pfizer, Inc. Company Details
Table 109. Pfizer, Inc. Business Overview
Table 110. Pfizer, Inc. Molecular Pharming Product
Table 111. Pfizer, Inc. Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 112. Pfizer, Inc. Recent Development
Table 113. ProdiGene Inc Company Details
Table 114. ProdiGene Inc Business Overview
Table 115. ProdiGene Inc Molecular Pharming Product
Table 116. ProdiGene Inc Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 117. ProdiGene Inc Recent Development
Table 118. Protalix Biotherapeutics, Inc Company Details
Table 119. Protalix Biotherapeutics, Inc Business Overview
Table 120. Protalix Biotherapeutics, Inc Molecular Pharming Product
Table 121. Protalix Biotherapeutics, Inc Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 122. Protalix Biotherapeutics, Inc Recent Development
Table 123. Tiamat Sciences Company Details
Table 124. Tiamat Sciences Business Overview
Table 125. Tiamat Sciences Molecular Pharming Product
Table 126. Tiamat Sciences Revenue in Molecular Pharming Business (2020-2025) & (US$ Million)
Table 127. Tiamat Sciences Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Molecular Pharming Picture
Figure 2. Global Molecular Pharming Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Molecular Pharming Market Share by Type: 2024 VS 2031
Figure 4. Gene Gun Features
Figure 5. Agroinfiltration Features
Figure 6. Electroporation Features
Figure 7. Agrobacterium-Mediated Gene Transfer Features
Figure 8. Global Molecular Pharming Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Molecular Pharming Market Share by Application: 2024 VS 2031
Figure 10. Recombinant Antibodies Case Studies
Figure 11. Hormones, Vaccines Case Studies
Figure 12. Industrial Enzymes Case Studies
Figure 13. Proteins & Protein-Based Materials Case Studies
Figure 14. Technical Reagents Case Studies
Figure 15. Nutritional Products Case Studies
Figure 16. Molecular Pharming Report Years Considered
Figure 17. Global Molecular Pharming Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Molecular Pharming Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Molecular Pharming Market Share by Region: 2024 VS 2031
Figure 20. Global Molecular Pharming Market Share by Players in 2024
Figure 21. Global Top Molecular Pharming Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Pharming as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Molecular Pharming Revenue in 2024
Figure 23. North America Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Molecular Pharming Market Share by Country (2020-2031)
Figure 25. United States Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Molecular Pharming Market Share by Country (2020-2031)
Figure 29. Germany Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Molecular Pharming Market Share by Region (2020-2031)
Figure 37. China Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Molecular Pharming Market Share by Country (2020-2031)
Figure 45. Mexico Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Molecular Pharming Market Share by Country (2020-2031)
Figure 49. Turkey Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Molecular Pharming Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Medicago Inc Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 53. Meristem Therapeutics S.A. (Ventria Bioscience) Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 54. Miruku Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 55. Moolec Science Limited Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 56. mozza Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 57. Nobell Foods Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 58. Agrenvec S.L Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 59. Bright Biotech Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 60. Core Biogenesis Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 61. Diamante SRL Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 62. Leaf Systems International Limited Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 63. ORF Genetics Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 64. Pfizer, Inc. Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 65. ProdiGene Inc Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 66. Protalix Biotherapeutics, Inc Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 67. Tiamat Sciences Revenue Growth Rate in Molecular Pharming Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232